166 related articles for article (PubMed ID: 37901406)
1. Chinese Clinical Trial Registry 13-year data collection and analysis: geographic distribution, financial support, research phase, duration, and disease categories.
Fan R; Zheng Y; Zhou R; Beeraka NM; Sukocheva OA; Zhao R; Li S; Zhao X; Liu C; He S; Mahesh PA; Gurupadayya BM; Nikolenko VN; Zhao D; Liu J
Front Med (Lausanne); 2023; 10():1203346. PubMed ID: 37901406
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics analysis of oral clinical trials registered in Chinese Clinical Trial Registry].
Zhang XL; Chen XB; Xia J; Tao XA
Zhonghua Kou Qiang Yi Xue Za Zhi; 2022 Sep; 57(9):946-952. PubMed ID: 36097942
[No Abstract] [Full Text] [Related]
4. Characteristics and trends of clinical studies primarily sponsored by China in WHO primary registries between 2009 and 2018: a cross-sectional survey.
Xu Y; Dong M; Liu X
BMJ Open; 2020 Nov; 10(11):e037262. PubMed ID: 33444176
[TBL] [Abstract][Full Text] [Related]
5. Status quo, issues, and challenges for acupuncture research evidence: an overview of clinical and fundamental studies.
Cai Y; Shen J; Zhong D; Li Y; Wu T
J Evid Based Med; 2012 Feb; 5(1):12-24. PubMed ID: 23528116
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Registration of intervention trials of Traditional Chinese Medicine for four neurological diseases on Chinese Clinical Trial Registry and ClinicalTrials.gov: a narrative review.
Wei JJ; Guo RJ; Fu GJ; Liang X; Xu ZM; Jia M; Zeng ZX; Du WQ; Jiao WW; Sun LJ; Liu HM; Guo CL; Tong CG; Zhang YL; Liao X
J Tradit Chin Med; 2022 Feb; 42(1):148-153. PubMed ID: 35294135
[TBL] [Abstract][Full Text] [Related]
8. [Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].
Wang H; Jin XY; Pang B; Liu CX; Zheng WK; Yang FW; Pang WT; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1232-1241. PubMed ID: 32281330
[TBL] [Abstract][Full Text] [Related]
9. Trends of Phase I Clinical Trials of New Drugs in Mainland China Over the Past 10 Years (2011-2020).
Chen C; Lou N; Zheng X; Wang S; Chen H; Han X
Front Med (Lausanne); 2021; 8():777698. PubMed ID: 34977078
[No Abstract] [Full Text] [Related]
10. Development of clinical trials for non-small cell lung cancer drugs in China from 2005 to 2023.
Jia W; Yu H; Song L; Wang J; Niu S; Zang G; Liang M; Liu J; Na R
Front Med (Lausanne); 2023; 10():1239351. PubMed ID: 38034540
[TBL] [Abstract][Full Text] [Related]
11. The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009-2021.
Li C; Hao J; Zheng Y; Wang C; Yang J; Wang W; Zhang K; Shao C; Hui W; Wang J; Li W; Tang YD
Diabetol Metab Syndr; 2023 Apr; 15(1):66. PubMed ID: 37005689
[TBL] [Abstract][Full Text] [Related]
12. Research Collaboration and Outcome Measures of Interventional Clinical Trial Protocols for COVID-19 in China.
Gao Y; Yang K; Liu M; Chen Y; Shi S; Yang F; Tian J
Front Public Health; 2020; 8():554247. PubMed ID: 32984256
[No Abstract] [Full Text] [Related]
13. Challenges for funders in monitoring compliance with policies on clinical trials registration and reporting: analysis of funding and registry data in the UK.
Knowles RL; Ha KP; Mueller J; Rawle F; Parker R
BMJ Open; 2020 Feb; 10(2):e035283. PubMed ID: 32071191
[TBL] [Abstract][Full Text] [Related]
14. Practices and trends in clinical trial registration in the Pan African Clinical Trials Registry (PACTR): a descriptive analysis of registration data.
Ndwandwe DE; Runeyi S; Pienaar E; Mathebula L; Hohlfeld A; Wiysonge CS
BMJ Open; 2022 Jan; 12(1):e057474. PubMed ID: 35078852
[TBL] [Abstract][Full Text] [Related]
15. Registered Clinical Trials Comprising Pregnant Women in China: A Cross-Sectional Study.
Zhao Y; Du G; Luan X; Yang H; Zhang Q; Zhang Z; Wang S
Front Pharmacol; 2022; 13():850080. PubMed ID: 35450038
[No Abstract] [Full Text] [Related]
16. The changing landscape of anti-lymphoma drug clinical trials in mainland China in the past 15 years (2005-2020): A systematic review.
Chen H; Zhou Y; Han X; Shi Y
Lancet Reg Health West Pac; 2021 Mar; 8():100097. PubMed ID: 34327425
[TBL] [Abstract][Full Text] [Related]
17. [Disease burden of colorectal cancer in China: any changes in recent years?].
Wang H; Cao MD; Liu CC; Yan XX; Huang HY; Zhang Y; Chen HD; Ren JS; Li N; Chen WQ; Dai M; Shi JF
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1633-1642. PubMed ID: 33297619
[No Abstract] [Full Text] [Related]
18. [Analysis of registration data for clinical trials of pneumoconiosis].
Zhao HL; Xie Y; Li JS
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Jan; 38(1):20-23. PubMed ID: 32062890
[No Abstract] [Full Text] [Related]
19. Characteristics of anticancer drug studies registered on the Chinese Clinical Trial Registry (ChiCTR) from 2007 to 2015.
Song M; Guo H; Chen H; Hu H
J Evid Based Med; 2016 May; 9(2):59-68. PubMed ID: 27203189
[TBL] [Abstract][Full Text] [Related]
20. The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020.
Zhong Q; Tao Y; Chen H; Zhou Y; Huang L; Han X; Shi Y
Lancet Reg Health West Pac; 2021 Jun; 11():100151. PubMed ID: 34327360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
